We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXP icon
226
American Express
AXP
$230B
$2.84M 0.03%
28,288
+7,587
+37% +$746K
LABU icon
227
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$631M
$2.83M 0.03%
2,639
+2,604
+7,440% +$2.99M
KNSL icon
228
Kinsale Capital Group
KNSL
$8.51B
$2.78M 0.03%
14,637
+12,425
+562% +$2.29M
CPRT icon
229
Copart
CPRT
$27.5B
$2.78M 0.03%
105,724
-53,024
-33% -$1.28M
KBR icon
230
KBR
KBR
$4.8B
$2.77M 0.03%
123,933
+74,342
+150% +$1.72M
SMCI icon
231
Super Micro Computer
SMCI
$20.1B
$2.77M 0.03%
1,048,210
+995,340
+1,883% +$2.72M
SEDG icon
232
SolarEdge
SEDG
$1.95B
$2.77M 0.03%
11,611
+32
+0.3% +$6.15K
BLKB icon
233
Blackbaud
BLKB
$2.08B
$2.76M 0.03%
49,432
+34,240
+225% +$2.05M
KRE icon
234
State Street SPDR S&P Regional Banking ETF
KRE
$4.57B
$2.76M 0.03%
77,297
+68,141
+744% +$2.57M
NGVT icon
235
Ingevity
NGVT
$2.68B
$2.75M 0.03%
55,550
+37,635
+210% +$2.12M
REGN icon
236
Regeneron Pharmaceuticals
REGN
$80.8B
$2.72M 0.03%
4,865
+333
+7% +$202K
RGEN icon
237
Repligen
RGEN
$9.25B
$2.72M 0.03%
18,407
-2,918
-14% -$417K
CVX icon
238
Chevron
CVX
$366B
$2.71M 0.03%
37,594
-14,907
-28% -$1.25M
CNO icon
239
CNO Financial Group
CNO
$5.1B
$2.7M 0.03%
168,262
+108,891
+183% +$1.75M
PRSP
240
DELISTED
Perspecta Inc. Common Stock
PRSP
$2.69M 0.03%
138,477
+80,092
+137% +$1.69M
ADSW
241
DELISTED
Advanced Disposal Services Inc
ADSW
$2.69M 0.03%
88,957
+33,621
+61% +$1.01M
NSP icon
242
Insperity
NSP
$2.01B
$2.69M 0.03%
41,034
+28,097
+217% +$1.87M
FNDA icon
243
Schwab Fundamental US Small Company Index ETF
FNDA
$9.38B
$2.68M 0.03%
162,122
-39,420
-20% -$662K
SSD icon
244
Simpson Manufacturing
SSD
$8.16B
$2.67M 0.03%
27,437
+22,781
+489% +$2.16M
AIMT
245
DELISTED
Aimmune Therapeutics
AIMT
$2.66M 0.03%
77,282
+61,204
+381% +$1.3M
IVE icon
246
iShares S&P 500 Value ETF
IVE
$49.8B
$2.66M 0.03%
23,664
-43,293
-65% -$4.91M
NEOG icon
247
Neogen
NEOG
$2.5B
$2.66M 0.03%
67,932
+56,266
+482% +$2.15M
DDM icon
248
ProShares Ultra Dow30
DDM
$548M
$2.65M 0.03%
113,306
+78,112
+222% +$1.77M
NOVT icon
249
Novanta
NOVT
$6.29B
$2.65M 0.03%
25,143
+20,409
+431% +$2.16M
ZD icon
250
Ziff Davis
ZD
$1.98B
$2.65M 0.03%
43,968
+28,515
+185% +$1.62M

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.